1. Hypersensitivity to Olmesartan medoxomil or any component of the formulation.
2. Second and third trimesters of pregnancy or lactation.
3. Patients with biliary obstruction.
4. Concomitant use with aliskiren in patients with diabetes mellitus.
Sign Out